Pregled bibliografske jedinice broj: 762544
Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers
Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers // Virchows Archiv, 466 (2015), 2; 185-189 doi:10.1007/s00428-014-1694-3 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 762544 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Flow cytometric dna hypertetraploidy tends to be more frequent in male than in female breast cancers
Autori
Bezić, Joško ; Šamija Projić, Ivana ; Projić, Petar ; Ljubković, Jelena ; Zekić Tomaš, Sandra ; Meljanac Salopek, Kristina ; Piljić Burazer, Marina ; Tomić, Snježana
Izvornik
Virchows Archiv (0945-6317) 466
(2015), 2;
185-189
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
male breast cancer; female breast cancer; DNA flow cytometry; ploidy; hypertetraploidy
Sažetak
The aim of the study was to explore possible differences in DNA flow cytometric characteristics, particularly differences in distribution of DNA indices of aneuploid clones, between male and female breast cancers. We retrospectively analyzed 31 male breast cancers. Clinicopathological and DNA flow cytometric characteristics of male breast cancers (patient age, tumor size, histological type, histological grade, axillary lymph node status, hormone receptor expression, ploidy, and Sphase fraction) were compared with that of the control group of matched female breast cancers. Hormone receptors and HER-2/ neu were investigated immunohistochemically with additional chromogenic in situ hybridization (CISH) analysis of HER-2/ neu 2+ cases. Ploidy and S-phase fraction were determined by DNA flow cytometry. Comparison with clinicopathological features was made using χ2 and t test. Aneuploidy was found in 78 % of the cases, with the predomination of hypotetraploid clones (39 %), followed by tetraploid (23 %) and hypertetraploid clones (16 %). We found higher frequency of hypertetraploidy in male breast cancers (16 and 6 %, respectively) than in the control group of matched female breast cancers. Clinicopathological features of hypertetraploid male breast cancers did not differ from that of non-hypertetraploid cancers. Higher frequency of hypertetraploidy among male breast cancers might indicate different cytogenetical evolutionary pathway between male and female breast cancer.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
KBC Split
Profili:
Sandra Zekić-Tomaš
(autor)
Snježana Tomić
(autor)
Kristina Meljanac Salopek
(autor)
Ivana Šamija
(autor)
Joško Bezić
(autor)
Jelena Ljubković
(autor)
Petar Projić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE